Kentaro Fujita, Embryologist at Kanagawa Ladies Clinic, Presents Research Findings at International Conference "ESHRE 42nd Annual Meeting"

Ensuring More Reliable Evaluation for Every Embryo: Sharing the Potential of a New Evaluation Metric Focusing on the Duration of Cytoplasmic Strings

IRVINE, Calif. -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) ("SBC Medical" or the "Company"), a Medical Services Organization operating a wide range of franchise businesses across diverse medical fields, today announced that Kentaro Fujita, an embryologist at Kanagawa Ladies Clinic, presented a poster at the "ESHRE 42nd Annual Meeting," held over four days starting Sunday, July 5, 2026, in London, U.K.

ESHRE (European Society of Human Reproduction and Embryology) is one of the world's largest international academic conferences in the fields of reproductive medicine and embryology. It brings together doctors, researchers, and embryologists involved in reproductive medicine from around the world to share the latest research findings and clinical insights.
At the "ESHRE 42nd Annual Meeting," Fujita presented a poster titled "Does the Duration of Cytoplasmic Strings in Blastocysts Affect Clinical Outcomes?" Cytoplasmic strings are believed to be potentially involved in embryo development, and with recent advancements in continuous embryo imaging technology, they are attracting attention as a new clue for identifying implantation potential. In this presentation, Fujita shared practical findings examining the relationship between the duration of cytoplasmic strings and clinical outcomes. The presentation garnered high interest from international doctors and researchers as it demonstrated the potential for more precise embryo selection and fertility treatments tailored to each customer.
As technological innovation continues to accelerate in the field of reproductive medicine, the importance of knowledge sharing and academic collaboration, beyond the clinical setting alone, has grown considerably. Meeting the increasingly diverse needs of customers requires not only the adoption of advanced techniques, but also broad perspectives and flexible thinking. SBC Medical remains committed to advancing cutting-edge initiatives through academic presentations and research collaborations, and to upholding the safety, transparency, and enduring value of reproductive medicine.

Overview of "ESHRE 42nd Annual Meeting" Venue: ExCeL London (London, U.K.) Dates: Sunday, July 5 to Wednesday, July 8, 2026 Official Website: https://www.eshre.eu/eshre2026

Presentation Title Does the Duration of Cytoplasmic Strings in Blastocysts Affect Clinical Outcomes?

About Kanagawa Ladies Clinic Kanagawa Ladies Clinic is a clinic specializing in fertility treatment and in vitro fertilization (IVF) based in Yokohama, Kanagawa Prefecture. With the motto of "a casual, convenient, and highly accessible clinic," it provides treatments tailored to the conditions and life stages of each customer. The clinic offers a wide range of services, from general fertility treatments to advanced reproductive medicine such as IVF and embryo transfer, under a highly specialized medical system. In addition, prioritizing accessibility and efficient consultation processes, the clinic is committed to providing medical care aimed at reducing the physical, emotional, and financial burdens on its customers. Official Website: https://www.klc.jp/

About SBC Medical Group Holdings Incorporated SBC Medical Group Holdings Incorporated is a Medical Services Organization providing management support across a wide range of healthcare fields, including advanced aesthetic healthcare, dermatology, orthopedics, fertility treatment, gynecology, dentistry, alopecia treatment (AGA), and ophthalmology. The Company manages a diverse portfolio of clinic brands and is actively expanding its global presence, particularly in the United States and Asia, through both direct operations and medical tourism initiatives. In September 2024, the Company was listed on Nasdaq, and in June 2025, it was selected for inclusion in the Russell 3000® Index, a broad benchmark of the U.S. equity market. Guided by its Group Purpose "Contributing to the well-being of people around the world through medical innovation," SBC Medical Group Holdings Incorporated continues to provide safe, trusted, and high-quality medical services while further strengthening its international reputation for quality and trust in medical care.
For more information, visit https://sbc-holdings.com
For more insights and updates from SBC Medical, follow us on Linkedin.

Forward-Looking Statements This press release contains forward-looking statements. Forward-looking statements are not historical facts or statements of current conditions, but instead represent only the Company's beliefs regarding future events and performance, many of which, by their nature, are inherently uncertain and outside of the Company's control. These forward-looking statements reflect the Company's current views with respect to, among other things, the Company's product launch plans and strategies; growth in revenue and earnings; and business prospects. In some cases, forward-looking statements can be identified by the use of words such as "may," "should," "expects," "anticipates," "contemplates," "estimates," "believes," "plans," "projected," "predicts," "potential," "targets" or "hopes" or the negative of these or similar terms. The Company cautions readers not to place undue reliance upon any forward-looking statements, which are current only as of the date of this release and are subject to various risks, uncertainties, assumptions, or changes in circumstances that are difficult to predict or quantify. The forward-looking statements are based on management's current expectations and are not guarantees of future performance. The Company does not undertake or accept any obligation to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based, except as required by law. Factors that may cause actual results to differ materially from current expectations may emerge from time to time, and it is not possible for the Company to predict all of them; such factors include, among other things, changes in global, regional, or local economic, business, competitive, market and regulatory conditions, and those listed under the heading "Risk Factors" and elsewhere in the Company's filings with the U.S. Securities and Exchange Commission (the "SEC"), which are accessible on the SEC's website at www.sec.gov.

Contacts
Hikaru Fukui / Head of IR Department; E-mail: ir@sbc-holdings.com
Akiko Wakiyama / Chief Public Relations Officer; E-mail: pr@sbc.or.jp